Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble CoInhibitory and CoStimulatory Immune Checkpoint Molecules

Simple item page
dc.citation.doi10.3389/FIMMU.2022.823842
dc.citation.epage10
dc.citation.spage1
dc.contributor.authorBernardo L. Rapoport
dc.contributor.authorHelen C. Steel
dc.contributor.authorNomsa Hlatshwayo
dc.contributor.authorAnnette J. Theron
dc.contributor.authorE et al
dc.contributor.authorSimon Nayler
dc.date.accessioned2023-10-12T07:37:55Z
dc.date.available2023-10-12T07:37:55Z
dc.identifier.citationWOS
dc.identifier.issn1664-3224
dc.identifier.urihttps://hdl.handle.net/10539/36715
dc.journal.titleFRONTIERS IN IMMUNOLOGY
dc.journal.volume13
dc.titleSystemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble CoInhibitory and CoStimulatory Immune Checkpoint Molecules

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal.pdf
Size:
711.87 KB
Format:
Adobe Portable Document Format
Description:
Journal
Download

Collections

Academic Wits Research Outputs (All submissions)